Characterization of TEM1/endosialin in human and murine brain tumors

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Carson Walter, Eleanor B ^a   Winans, Bethany N ^a   Whiteman, Melissa C ^a   Liu, Yang ^a   Jarvela, Sally ^b   Haapasalo, Hannu ^b   Tyler, Betty M ^c   Huso, David L ^c   Johnson, Mahlon D ^a   Walter, Kevin A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; ENDOSIALIN; FIBRONECTIN; CD248 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN TUMOR; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STROMA CELL; TISSUE MICROARRAY; TUMOR GROWTH; UPREGULATION; WILD TYPE; XENOGRAFT; AGE; ANIMAL; BIOSYNTHESIS; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION;

AGE FACTORS; ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 72549107748     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-417     Document Type: Article

References (33)

1. Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, Walter-Yohrling J. Vascular gene expression in nonneoplastic and malignant brain. The American journal of pathology 2004, 165(2):601-608. 1618572, 15277233.
2. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B. Genes expressed in human tumor endothelium. Science (New York, NY) 2000, 289(5482):1197-1202.
3. Christian S, Ahorn H, Koehler A, Eisenhaber F, Rodi HP, Garin-Chesa P, Park JE, Rettig WJ, Lenter MC. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. The Journal of biological chemistry 2001, 276(10):7408-7414. 10.1074/jbc.M009604200, 11084048.
4. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(22):10832-10836. 10.1073/pnas.89.22.10832, 50436, 1438285.
5. Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008, 21(3):308-315. 10.1038/modpathol.3801006, 18192970.
6. Davies G, Cunnick GH, Mansel RE, Mason MD, Jiang WG. Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clinical & experimental metastasis 2004, 21(1):31-37. 10.1023/B:CLIN.0000017168.83616.d0, 15065600.
7. Brady J, Neal J, Sadakar N, Gasque P. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors. Journal of neuropathology and experimental neurology 2004, 63(12):1274-1283.
8. MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, Panico M, Sutton-Smith M, Dell A, Geer P. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS letters 2005, 579(12):2569-2575. 10.1016/j.febslet.2005.03.071, 15862292.
9. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer research 2001, 61(18):6649-6655.
10. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, Augustin HG. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. The American journal of pathology 2008, 172(2):486-494. 10.2353/ajpath.2008.070623, 2312374, 18187565.
11. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, Sass P, Nicolaides NC, Grasso L, Zhou Y. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(46):17965-17970. 10.1073/pnas.0705647104, 2084280, 17986615.
12. Becker R, Lenter MC, Vollkommer T, Boos AM, Pfaff D, Augustin HG, Christian S. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. Faseb J 2008, 22(8):3059-3067. 10.1096/fj.07-101386, 18490383.
13. Nanda A, Karim B, Peng Z, Liu G, Qiu W, Gan C, Vogelstein B, St Croix B, Kinzler KW, Huso DL. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(9):3351-3356. 10.1073/pnas.0511306103, 1413931, 16492758.
14. Carson-Walter EB, Hampton J, Shue E, Geynisman DM, Pillai PK, Sathanoori R, Madden SL, Hamilton RL, Walter KA. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res 2005, 11(21):7643-7650. 10.1158/1078-0432.CCR-05-1099, 16278383.
15. Nordfors K, Haapasalo J, Helen P, Paetau A, Paljarvi L, Kalimo H, Kinnula VL, Soini Y, Haapasalo H. Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas. Clinical neuropathology 2007, 26(5):210-218.
16. Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, Chen J, Walter KA. Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models. BMC neuroscience 2008, 9:29. 10.1186/1471-2202-9-29, 2270280, 18302779.
17. Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, Ishida I, Roberts BL, Teicher BA. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. International journal of oncology 2009, 34(3):619-627. 10.3892/ijo_00000187, 19212666.
18. Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvascular research 2008, 79(3):180-188.
19. MacFadyen J, Savage K, Wienke D, Isacke CM. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Expr Patterns 2007, 7(3):363-369. 10.1016/j.modgep.2006.07.006, 16965941.
20. Bagley RG, Rouleau C, St Martin T, Boutin P, Weber W, Ruzek M, Honma N, Nacht M, Shankara S, Kataoka S. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Molecular cancer therapeutics 2008, 7(8):2536-2546. 10.1158/1535-7163.MCT-08-0050, 18723498.
21. Rouleau C, Curiel M, Weber W, Smale R, Kurtzberg L, Mascarello J, Berger C, Wallar G, Bagley R, Honma N. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Clin Cancer Res 2008, 14(22):7223-7236. 10.1158/1078-0432.CCR-08-0499, 19010839.
22. Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges MC, Rubin SC, Carroll RG, Coukos G. Vascular leukocytes contribute to tumor vascularization. Blood 2005, 105(2):679-681. 10.1182/blood-2004-05-1906, 15358628.
23. Tentori L, Vergati M, Muzi A, Levati L, Ruffini F, Forini O, Vernole P, Lacal PM, Graziani G. Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. International journal of oncology 2005, 27(2):525-535.
24. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. The Journal of clinical investigation 2003, 111(9):1287-1295. 154450, 12727920.
25. Cao Y, Sonveaux P, Liu S, Zhao Y, Mi J, Clary BM, Li CY, Kontos CD, Dewhirst MW. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer research 2007, 67(8):3835-3844. 10.1158/0008-5472.CAN-06-4056, 17440098.
26. Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer research 2006, 66(18):9054-9064. 10.1158/0008-5472.CAN-05-3759, 16982747.
27. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121(3):335-348. 10.1016/j.cell.2005.02.034, 15882617.
28. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer research 2007, 67(21):10123-10128. 10.1158/0008-5472.CAN-07-3127, 17974953.
29. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G. Long-term survival with glioblastoma multiforme. Brain 2007, 130(Pt 10):2596-2606. 10.1093/brain/awm204, 17785346.
30. Virgintino D, Girolamo F, Errede M, Capobianco C, Robertson D, Stallcup WB, Perris R, Roncali L. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis 2007, 10(1):35-45. 10.1007/s10456-006-9061-x, 17225955.
31. Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, Tofilon PJ. Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(23):8287-8292. 10.1073/pnas.0502887102, 1142119,1142119, 15928080.
32. Ohradanova A, Gradin K, Barathova M, Zatovicova M, Holotnakova T, Kopacek J, Parkkila S, Poellinger L, Pastorekova S, Pastorek J. Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2. British journal of cancer 2008, 99(8):1348-1356. 10.1038/sj.bjc.6604685, 2570523, 18813310.
33. Marty C, Langer-Machova Z, Sigrist S, Schott H, Schwendener RA, Ballmer-Hofer K. Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. Cancer letters 2006, 235(2):298-308. 10.1016/j.canlet.2005.04.029, 15953677.